Joel Sussman

Sussman was born in Philadelphia, Pennsylvania.

In 1965, Sussman received his B.A. at Cornell University in math and physics. He received his PhD from MIT in biophysics in 1972, having worked with Cyrus Levinthal. Sussman conducted postdoctoral research in the Hebrew University of Jerusalem in 1972, with Yehuda Lapidot, and in the Duke University in 1973 with Sung-Hou Kim.

Sussman has been a Professor at the Weizmann Institute of Science since 1976.

• 1984–85 – Head, Department of Structural Chemistry
• 1988–89 – Head, Kimmelman Center for Biomolecular Structure and Assembly
• 2002–14 – Incumbent of the Morton and Gladys Pickman Chair of Structural Biology
• 2016-now – Professor Emeritus

In 1994–99, he was also the director of the Protein Data Bank (PDB) at the Brookhaven National Laboratory.

Sussman was a pioneer of macromolecular refinement, developing CORELS and applying it to yeast tRNA^phe.[1][2] He subsequently determined the structures of 'bulge'-containing DNA fragments as models for insertion mutations.[3]

Sussman's current research focuses on nervous system proteins, especially acetylcholinesterase (AChE), whose 3D structure was first determined in his lab. This structure revealed:

• AChE is a prototype of the α/β hydrolase fold;[4]
• π-cation interactions play a key role in binding of acetylcholine (ACh) and ligands to AChE;[4]
• Its ACh-binding site assisted in structure-based design of promising leads for novel anti-Alzheimer's drugs;
• Discovered a highly asymmetric charge distribution[5] conserved in 'cholinesterase-like adhesion molecules' (CLAMs), and showed that their cytoplasmic domains are 'intrinsically disordered'[6] with implications for neural development and plasticity, and led to an algorithm, FoldIndex,[7] for predicting whether a protein sequence will fold;
• The specific chemical and structural damage to proteins produced by synchrotron radiation, e.g. cleavage of a specific disulfide bond even at cryo temperatures.[8]

He has investigated the molecular basis for halophilicity[9] and halotolerance,[10] shedding light on how proteins function over extreme ranges of salt concentration, with unexpected implications for kidney diseases. He determined the structures of Glucocerebrosidase,[11] a protein defective in Gaucher disease, paving the way to novel therapeutic approaches, and of paraoxonase,[12] a protein relevant to treatment of atherosclerosis.

• 2014 - Ilanit-Katzir Prize for exceptional achievements in the field of Life Sciences (together with Israel Silman)
• 2006 – Teva Founders' Award for breakthroughs in molecular medicine (together with Hermona Soreq and Israel Silman).
• 2005 – Honorary Professor, Chinese Academy of Sciences
• 2005 – Samuel and Paula Elkeles Prize for Outstanding Scientist in the field of medicine in Israel (together with Israel Silman)
• 1994 – Elected member, European Molecular Biology Organization (EMBO)

• Joel Sussman at the Weizmann Institute
• The Israel Structural Proteomics Center